EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+27.65%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$204M
AUM Growth
+$48.5M
(+31%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
11.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
Venus Concept
VERO
|
+$18.8M |
| 2 |
TELA Bio
TELA
|
+$4.12M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
| $81.6M | 40.04% |
3,342,047
| – | – |
|
|
2
Venus Concept
VERO
$4.37M
| $43.3M | 21.26% |
75,260
+32,728
| +77% | +$18.8M |
|
3
EyePoint Pharmaceuticals
EYPT
$941M
| $31.9M | 15.62% |
4,190,922
| – | – |
|
4
Axogen
AXGN
$774M
| $22.5M | 11.01% |
2,429,999
| – | – |
|
|
5
TELA Bio
TELA
$61M
| $18M | 8.85% |
1,391,768
+317,537
| +30% | +$4.12M |
|
6
MediciNova
MNOV
$60.3M
| $5.99M | 2.94% |
1,105,941
| – | – |
|
7
Gyre Therapeutics
GYRE
$684M
| $462K | 0.23% |
10,483
| – | – |
|
|
ELGX
8
DELISTED
Endologix Inc
ELGX
| $101K | 0.05% |
125,747
| – | – |
|